Mid-Trimester Maternal ADAM12 Levels Differ According to Fetal Gender in Pregnancies Complicated by Preeclampsia

Abstract

An overrepresentation of adverse pregnancy outcomes has been observed in pregnancies associated with a male fetus. We investigated the association between fetal gender and candidate biomarkers for preeclampsia. Proteins were quantified in samples taken at 20 weeks from women recruited to the SCreening fOr Pregnancy Endpoints (SCOPE) study (preeclampsia n = 150; no preeclampsia n = 450). In contrast to placental growth factor, soluble endoglin, and insulin-like growth factor acid labile subunit, levels of metallopeptidase domain 12 (ADAM12) at 20 weeks were dependent on fetal gender in pregnancies complicated by preeclampsia, for male (n = 73) fetuses the multiples of the median (MoM; interquartile range [IQR] 1.1-1.5) was 1.3, whereas for female fetuses (n = 75) MoM was 1.1 (1.0-1.3); P < .01. Prediction of preeclampsia using ADAM12 levels was improved for pregnancies associated with a male fetus (area under receiver–operator curve [AUC] 0.73 [95% confidence interval [CI] 0.67-0.80]) than that of a female fetus (AUC 0.62 [0.55-0.70]); P = .03. The data presented here fit a contemporary hypothesis that there is a difference between the genders in response to an adverse maternal environment and suggest that an alteration in ADAM12 may reflect an altered placental response in pregnancies subsequently complicated by preeclampsia.

Keywords

preeclampsia mass spectrometry biomarkers fetal sex ADAM12

Get full access to this article

View all access options for this article.

References

Byrne

Warburton

. Male excess among anatomically normal fetuses in spontaneous abortions. Am J Med Genet. 1987;26(3):605–611.

James

. Sex ratios of offspring and the causes of placental pathology. Human Reproduction. 1995;10(6):1403–1406.

Vatten

Skjaerven

. Offspring sex and pregnancy outcome by length of gestation. Early Hum Dev. 2004;76(1):47–54.

Edwards

Megens

Peek

Wallace

. Sexual origins of placental dysfunction. Lancet. 2000;355(9199):203–204.

Walker

Fitzgerald

Keating

Ray

Windrim

Kingdom

. Sex-specific basis of severe placental dysfunction leading to extreme preterm delivery. Placenta. 2012;33(7):568–571.

Sood

Zehnder

Druzin

Brown

. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A. 2006;103(14):5478–5483.

Clifton

. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31 suppl:S33–S39.

World Health Organisation. The World Health Report 2005 - Make Every Mother and Child Count. Geneva: World Health Organisation; 2005.

Centre for Maternal and Child Enquiries (CMACE). Perinatal Mortality 2009: United Kingdom. London: CMACE; 2011.

10.

Bukowski

. Stillbirth and fetal growth restriction. Clin Obstet Gynecol. 2010;53(3):673–680.

11.

Barker

. Fetal growth and adult disease. Br J Obstet Gynaecol. 1992;99(4):275–276.

12.

North

McCowan

Dekker

. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 2011;342(1):d1875.

13.

Kenny

Broadhurst

Dunn

. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension. 2010;56(4):741–749.

14.

Akolekar

Syngelaki

Sarquis

Zvanca

Nicolaides

. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31(1):66–74.

15.

Myatt

Clifton

Roberts

. First-trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol. 2012;119(6):1234–1242.

16.

Myers

Kenny

McCowan

. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG. 2013;120(10):1215–1223. doi: 10.1111/471-0528.12195.

17.

Poon

Chelemen

Granvillano

Pandeva

Nicolaides

. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol. 2008;112(5):1082–1090.

18.

Laigaard

Sorensen

Placing

. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol. 2005;106(1):144–149.

19.

Spencer

Cowans

Stamatopoulou

. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn. 2008;28(3):212–216.

20.

Matwejew

Cowans

Stamatopoulou

Spencer

von Kaisenberg

. Maternal serum ADAM-12 as a potential marker for different adverse pregnancy outcomes. Fetal Diagn Ther. 2010;27(1):32–39.

21.

Myers

Tuytten

Thomas

. Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia. Hypertension. 2013;61(6):1281–1288.

22.

Gentleman

Hornik

Leisch

. R 1.5 and the Bioconductor 1.0 releases. Comput Stat Data Analysis. 2002;39(4):557–558.

23.

Gilpin

Loechel

Mattei

Engvall

Albrechtsen

Wewer

. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem. 1998;273(1):157–166.

24.

Laigaard

Sorensen

Frohlich

. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn. 2003;23(13):1086–1091.

25.

Sahraravand

Jarvela

Laitinen

Tekay

Ryynanen

. The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. Placenta. 2011;32(12):999–1003.

26.

Christians

Gruslin

. Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010;30(9):815–820.

27.

Cowans

Spencer

. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn. 2007;27(3):264–271.

28.

Laigaard

Larsen

Pedersen

. ADAM 12-S in first trimester: fetal gender, smoking and maternal age influence the maternal serum concentration. Prenat Diagn. 2009;29(5):525–527.

29.

Bestwick

George

Morris

Wald

. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia. J Med Screen. 2012;19(1):51–54.

30.

Geary

Pringle

Rodeck

Kingdom

Hindmarsh

. Sexual dimorphism in the growth hormone and insulin-like growth factor axis at birth. J Clin Endocrinol Metab. 2003;88(8):3708–3714.

31.

Clifton

Hodyl

Murphy

Giles

Baxter

Smith

. Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis. Growth Horm IGF Res. 2010;20(1):39–48.

32.

Iniguez

Argandona

Medina

. Acid-labile subunit (ALS) gene expression and protein content in human placentas: differences according to birth weight. J Clin Endocrinol Metab. 2011;96(1):187–191.

33.

Baxter

. Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metabol. 1990;70(5):1347–1353.